These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24466071)
1. The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review. van den Hoven AF; Smits ML; Rosenbaum CE; Verkooijen HM; van den Bosch MA; Lam MG PLoS One; 2014; 9(1):e86394. PubMed ID: 24466071 [TBL] [Abstract][Full Text] [Related]
2. [An effect of the intra-arterial infusion of angiotensin II in the chemotherapy of human hepatic cancer]. Sasaki Y; Imaoka S; Ohigashi H; Ishikawa O; Koyama H; Iwanaga T; Hasegawa Y; Nakano S; Fujita M Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1456-63. PubMed ID: 3729462 [TBL] [Abstract][Full Text] [Related]
3. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Sasaki Y; Imaoka S; Hasegawa Y; Nakano S; Ishikawa O; Ohigashi H; Taniguchi K; Koyama H; Iwanaga T; Terasawa T Cancer; 1985 Jan; 55(2):311-6. PubMed ID: 2981143 [TBL] [Abstract][Full Text] [Related]
10. Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes. Piana PM; Bar V; Doyle L; Anne R; Sato T; Eschelman DJ; McCann JW; Gonsalves CF; Brown DB HPB (Oxford); 2014 Apr; 16(4):336-41. PubMed ID: 23782387 [TBL] [Abstract][Full Text] [Related]
11. Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study. Aarts BM; Klompenhouwer EG; Dresen RC; Deroose CMALO; Beets-Tan RGH; Punie K; Neven P; Wildiers H; Maleux G Radiol Oncol; 2020 Jan; 54(1):33-39. PubMed ID: 31967966 [TBL] [Abstract][Full Text] [Related]
12. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019 [TBL] [Abstract][Full Text] [Related]
13. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181 [TBL] [Abstract][Full Text] [Related]
14. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization. Ezponda A; RodrÃguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672 [TBL] [Abstract][Full Text] [Related]
15. Modulation of liver tumor blood flow with hepatic arterial epinephrine: a SPECT study. Andrews JC; Walker-Andrews SC; Juni JE; Warber S; Ensminger WD Radiology; 1989 Dec; 173(3):645-7. PubMed ID: 2813766 [TBL] [Abstract][Full Text] [Related]
16. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. Brown DB; Nikolic B; Covey AM; Nutting CW; Saad WE; Salem R; Sofocleous CT; Sze DY; J Vasc Interv Radiol; 2012 Mar; 23(3):287-94. PubMed ID: 22284821 [No Abstract] [Full Text] [Related]
17. [Hepatic hemodynamic changes in liver cancer patients during intrahepatic arterial angiotensin II infusion induced hypertension and chemoembolization]. Jiang XQ; Yin GF; Lu XX Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):647-9. PubMed ID: 7774400 [TBL] [Abstract][Full Text] [Related]
18. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503 [TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. Maleux G; Deroose C; Laenen A; Verslype C; Heye S; Haustermans K; De Hertogh G; Sagaert X; Topal B; Aerts R; Prenen H; Vanbeckevoort D; Vandecaveye V; Van Cutsem E Acta Oncol; 2016; 55(4):486-95. PubMed ID: 26625262 [TBL] [Abstract][Full Text] [Related]
20. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy. Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]